Latest news

A New Approach to TDM of Tobramycin in CF
16 Jun 2017 | Case Study

A New Approach to TDM of Tobramycin in CF

In this case review series by The Dosing Institute, DoseMe - a precision dosing software platform - is shown to be more accurate at estimating AUC than the conventional two-sample method, while requiring only one blood sample and allowing the collection of this sample at almost any patient-preferred time. Introduction Intravenous (IV) tobramycin, an aminoglycoside...

Read more
DoseMe Provides Dose of Advice to Queensland’s Top Innovators at QLD iAwards
6 Jun 2017 | Company Announcement

DoseMe Provides Dose of Advice to Queensland’s Top Innovators at QLD iAwards

Brisbane, QLD, Australia - DoseMe’s Charles Cornish will address Queensland’s newest innovators at the QLD iAwards Gala dinner on Wednesday, 7 June 2017. The QLD iAwards recognizes top Queenslanders at the cutting edge of digital innovation and is a platform for innovators to showcase their new ideas – everyone from...

Read more
DoseMeRx ASHP Summer Debut
1 Jun 2017 | Media Release

DoseMeRx ASHP Summer Debut

Australian founded software company DoseMe will launch US precision dosing clinical decision support solution - DoseMeRx - at the upcoming American Society of Health-System Pharmacists (ASHP) Summer meeting. DoseMeRx is built on the same algorithms that underpin the DoseMe platform of real-time dose-related clinical decision support with tailored enhancements for...

Read more
DoseMe set to deliver precision dosing at eHealth QLD Expo
15 May 2017 | Company Statement

DoseMe set to deliver precision dosing at eHealth QLD Expo

When the doors open to Queensland’s largest digital health event in May, DoseMe - the world’s first precision dosing software platform for clinical practice - will be delivering everyone the right dose of precision medicine. The expo brings together clinicians, healthcare professionals, IT experts, and vendors to focus on advancing...

Read more
DoseMeRx Rated Most User-Friendly in Clinical Study -Read the study →

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.